Real-time monitoring of hydrogen cyanide (HCN) and ammonia (NH3) emitted by Pseudomonas aeruginosa

Journal of Breath Research

Volumn 9, Issue 2, 2015, Pages

  Neerincx, Anne H ^a,b   Mandon, Julien ^a   Van Ingen, Jakko ^b   Arslanov, Denis D ^a   Mouton, Johan W ^b,c   Harren, Frans J M ^a   Merkus, Peter J F M ^b,d   Cristescu, Simona M ^a  

^a RADBOUD UNIVERSITY NIJMEGEN   (Netherlands)

^b RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^c ERASMUS MEDICAL CENTER   (Netherlands)

^d CANISIUS WILHELMINA HOSPITAL   (Netherlands)

Author keywords

ammonia, laser based photoacoustic spectroscopy; cystic fibrosis; hydrogen cyanide; Pseudomonas aeruginosa

Indexed keywords

AMMONIA; HYDROGEN CYANIDE; TOBRAMYCIN;

AMMONIA FORMATION; ANTIBIOTIC THERAPY; ARTICLE; BACTERIAL GROWTH; BACTERIAL STRAIN; BACTERIUM ISOLATE; BURKHOLDERIA CEPACIA; COLONY FORMING UNIT; CONTROLLED STUDY; CYSTIC FIBROSIS; GROWTH CURVE; HUMAN; IN VITRO STUDY; NONHUMAN; PHOTOACOUSTIC SPECTROSCOPY; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; TEMPERATURE; BACTERIAL COUNT; DRUG EFFECTS; GROWTH, DEVELOPMENT AND AGING; ISOLATION AND PURIFICATION; METABOLISM; MICROBIAL SENSITIVITY TEST; MICROBIOLOGY;

AMMONIA; COLONY COUNT, MICROBIAL; CYSTIC FIBROSIS; HUMANS; HYDROGEN CYANIDE; MICROBIAL SENSITIVITY TESTS; PSEUDOMONAS AERUGINOSA; TOBRAMYCIN;

EID: 84924322587     PISSN: 17527155     EISSN: 17527163     Source Type: Journal    
DOI: 10.1088/1752-7155/9/2/027102     Document Type: Article

References (30)

1. Ryall B, Davies J C, Wilson R, Shoemark A and Williams H D 2008 Pseudomonas aeruginosa, cyanide accumulation and lung function in CF and non-CF bronchiectasis patients Eur. Respir. J 32 740-7
2. Rosenfeld M, Gibson R L, McNamara S, Emerson J, Burns J L, Castile R, Hiatt P, McCoy K, Wilson C B and Inglis A 2001 Early pulmonary infection, inflammation, and clinical outcomes in infants with cystic fibrosis Pediatr. Pulmonol. 32 356-66
3. Graffelman A W, Willemssen F E, Zonderland H M, Neven A K, Kroes A C and van den Broek P J 2008 Limited value of chest radiography in predicting aetiology of lower respiratory tract infection in general practice Br. J. Gen. Pract. 58 93-7
4. Sanderson K, Wescombe L, Kirov S M, Champion A and Reid D W 2008 Bacterial cyanogenesis occurs in the cystic fibrosis lung Eur. Respir. J 32 329-33
5. Williams H D, Zlosnik J E A and Ryall B 2006 Oxygen, cyanide and energy generation in the cystic fibrosis pathogen Pseudomonas aeruginosa Adv. Microb. Physiol. 52 1-71
6. Carroll W, Lenney W, Wang T, Španěl P, Alcock A and Smith D 2005 Detection of volatile compounds emitted by Pseudomonas aeruginosa using selected ion flow tube mass spectrometry Pediatr. Pulmonol. 39 452-6
7. Gilchrist F J, Alcock A, Belcher J, Brady M, Jones A, Smith D, Španl P, Webb K and Lenney W 2011 Variation in hydrogen cyanide production between different strains of Pseudomonas aeruginosa Eur. Respir. J 38 409-14
8. Shestivska V, Španěl P, Dryahina K, Sovová K, Smith D, Musílek M and Nemec A 2012 Variability in the concentrations of volatile metabolites emitted by genotypically different strains of Pseudomonas aeruginosa J. Appl. Microbiol. 113 701-13
9. Enderby B, Smith D, Carroll W and Lenney W 2009 Hydrogen cyanide as a biomarker for Pseudomonas aeruginosa in the breath of children with cystic fibrosis Pediatr. Pulmonol. 44 142-7
10. Gilchrist F J, Bright-Thomas R J, Jones A M, Smith D, Španěl P, Webb A K and Lenney W 2013 Hydrogen cyanide concentrations in the breath of adult cystic fibrosis patients with and without Pseudomonas aeruginosa infection J. Breath Res. 7 026010
11. Dummer J, Storer M, Sturney S, Scott-Thomas A, Chambers S, Swanney M and Epton M 2013 Quantification of hydrogen cyanide (HCN) in breath using selected ion flow tube mass spectrometry - HCN is not a biomarker of Pseudomonas in chronic suppurative lung disease J. Breath Res. 7 017105
12. Gilchrist F J, Sims H, Alcock A, Belcher J, Jones A M, Smith D, Spanel P, Webb A K and Lenney W 2012 Quantification of hydrogen cyanide and 2-aminoacetophenone in the headspace of Pseudomonas aeruginosa cultured under biofilm and planktonic conditions Anal. Methods 4 3661-5
13. Chippendale T W, Gilchrist F J, Španěl P, Alcock A, Lenney W and Smith D 2014 Quantification by SIFT-MS of volatile compounds emitted by Aspergillus fumigatus cultures and in co-culture with Pseudomonas aeruginosa, Staphylococcus aureus and Streptococcus pneumonia Anal. Methods 6 2460-72
14. Smith D, Španěl P, Gilchrist F J and Lenney W 2013 Hydrogen cyanide, a volatile biomarker of Pseudomonas aeruginosa infection J. Breath Res. 7 044001
15. Nawaz M S, Davis J W, Wolfram J H and Chapatwala K D 1991 Degradation of organic cyanides by Pseudomonas aeruginosa Appl. Biochem. Biotechnol. 28-29 865-75
16. Arslanov D D, Castro M P, Creemers N A, Neerincx A H, Spunei M, Mandon J, Cristescu S M, Merkus P and Harren F J 2013 Optical parametric oscillator-based photoacoustic detection of hydrogen cyanide for biomedical applications J. Biomed. Opt. 18 107002
17. Blumer C and Haas D 2000 Mechanism, regulation, and ecological role of bacterial cyanide biosynthesis Arch. Microbiol. 173 170-7
18. Worlitzsch D, Tarran R, Ulrich M, Schwab U, Cekici A, Meyer K C, Birrer P, Bellon G, Berger J and Weiss T 2002 Effects of reduced mucus oxygen concentration in airway Pseudomonas infections of cystic fibrosis patients J. Clin. Invest. 109 317-25
19. Castric P A 1975 Hydrogen cyanide, a secondary metabolite of Pseudomonas aeruginosa Can. J. Microbiol. 21 613-18
20. Wissing F 1974 Cyanide formation from oxidation of glycine by a Pseudomonas species J. Bacteriol. 117 1289-94
21. Castric P A, Ebert R F and Castric K F 1979 The relationship between growth phase and cyanogenesis in Pseudomonas aeruginosa Curr. Microbiol. 2 287-92
22. Carterson A J, Morici L A, Jackson D W, Frisk A, Lizewski S E, Jupiter R, Simpson K, Kunz D A, Davis S H and Schurr J R 2004 The transcriptional regulator AlgR controls cyanide production in Pseudomonas aeruginosa J. Bacteriol. 186 6837-44
23. Stutz M D, Gangell C L, Berry L J, Garratt L, Sheil B and Sly P 2011 Cyanide in bronchoalveolar lavage is not diagnostic for Pseudomonas aeruginosa in children with cystic fibrosis Eur. Respir. J 37 553-8
24. Fernandez R F and Kunz D A 2005 Bacterial cyanide oxygenase is a suite of enzymes catalyzing the scavenging and adventitious utilization of cyanide as a nitrogenous growth substrate J. Bacteriol. 187 6396-402
25. Chippendale T W, Gilchrist F J, Španěl P, Alcock A, Lenney W and Smith D 2014 Quantification by SIFT-MS of volatile compounds emitted by in vitro cultures of S. aureus, S. pneumoniae and H. influenzae isolated from patients with respiratory diseases Anal. Methods 6 2460-72
26. Cipollone R, Ascenzi P, Frangipani E and Visca P 2006 Cyanide detoxification by recombinant bacterial rhodanese Chemosphere 63 942-9
27. Cipollone R, Bigotti M G, Frangipani E, Ascenzi P and Visca P 2004 Characterization of a rhodanese from the cyanogenic bacterium Pseudomonas aeruginosa Biochem. Biophys. Res. Commun. 325 85-90
28. Shawar R M, MacLeod D L, Garber R L, Burns J L, Stapp J R, Clausen C R and Tanaka S 1999 Activities of tobramycin and six other antibiotics against Pseudomonas aeruginosa isolates from patients with cystic fibrosis Antimicrob. Agents Chemother. 43 2877-80
29. Ryall B, Lee X, Zlosnik J E, Hoshino S and Williams H D 2008 Bacteria of the Burkholderia cepacia complex are cyanogenic under biofilm and colonial growth conditions BMC microbiol. 8 108
30. Gilchrist F J, Sims H, Alcock A, Jones A M, Bright-Thomas R J, Smith D, Španl P, Webb A K and Lenney W 2013 Is hydrogen cyanide a marker of Burkholderia cepacia complex? J. Clin. Microbiol. 51 3849-51